As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...
Hosted on MSN
Pfizer (PFE), Moderna (MRNA) Stocks Slide on Report Linking Child Deaths to COVID Vaccines
Shares of vaccine manufacturers Pfizer (PFE), BioNTech (BNTX), and Moderna (MRNA) fell 7%, 8%, and 4%, respectively, on Friday. The decline followed a report that officials from the Trump ...
Pfizer Inc.'s (NYSE:PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results